Distinction of IgG4-related mastitis from breast cancer: a case report.

Breast cancer IgG4-related mastitis IgG4-related sclerosing disease Steroid therapy

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
31 Jul 2019
Historique:
received: 04 09 2018
accepted: 22 07 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 2 8 2019
Statut: epublish

Résumé

Immunoglobulin (Ig) G4-related sclerosing disease is a pathological concept proposed in Japan during the early 2000s. This lesion-forming disease may exhibit characteristics of a systemic disease but often affects a single organ. To date, IgG4-related sclerosing disease in the mammary gland, or IgG4-related mastitis (IgG4-RM), has rarely been reported. Here, we describe the case of a female patient who was admitted to our hospital with the main complaints of left breast and axillary lymphadenopathy. A careful diagnostic imaging examination led to an initial suspicion of breast cancer. However, a needle biopsy led to a diagnosis of IgG4-RM. Subsequently, the patient was successfully treated with predonin. The treatment requirements for breast cancer and IgG4-RM differ considerably. This is a good example of a case wherein unnecessary surgical treatment, which is indicated for breast cancer, was avoided by needle biopsy. Accordingly, the patient was appropriately treated with steroids following a correct diagnosis.

Sections du résumé

BACKGROUND BACKGROUND
Immunoglobulin (Ig) G4-related sclerosing disease is a pathological concept proposed in Japan during the early 2000s. This lesion-forming disease may exhibit characteristics of a systemic disease but often affects a single organ. To date, IgG4-related sclerosing disease in the mammary gland, or IgG4-related mastitis (IgG4-RM), has rarely been reported.
CASE PRESENTATION METHODS
Here, we describe the case of a female patient who was admitted to our hospital with the main complaints of left breast and axillary lymphadenopathy. A careful diagnostic imaging examination led to an initial suspicion of breast cancer. However, a needle biopsy led to a diagnosis of IgG4-RM. Subsequently, the patient was successfully treated with predonin.
CONCLUSIONS CONCLUSIONS
The treatment requirements for breast cancer and IgG4-RM differ considerably. This is a good example of a case wherein unnecessary surgical treatment, which is indicated for breast cancer, was avoided by needle biopsy. Accordingly, the patient was appropriately treated with steroids following a correct diagnosis.

Identifiants

pubmed: 31367855
doi: 10.1186/s40792-019-0681-y
pii: 10.1186/s40792-019-0681-y
pmc: PMC6669223
doi:

Types de publication

Journal Article

Langues

eng

Pagination

123

Références

J Gastroenterol. 2003;38(10):982-4
pubmed: 14614606
Am J Surg Pathol. 2005 Feb;29(2):275-8
pubmed: 15644785
J Gastroenterol. 2006 Jul;41(7):613-25
pubmed: 16932997
Am J Surg Pathol. 2008 May;32(5):671-81
pubmed: 18344866
World J Gastroenterol. 2008 Jul 7;14(25):3948-55
pubmed: 18609677
Am J Surg Pathol. 2009 Jul;33(7):1058-64
pubmed: 19384187
Histopathology. 2009 Oct;55(4):373-83
pubmed: 19817887
Scand J Gastroenterol. 2009;44(12):1391-407
pubmed: 19958057
J Clin Rheumatol. 2009 Oct;15(7):354-7
pubmed: 20009972
Mod Rheumatol. 2012 Feb;22(1):1-14
pubmed: 21881964
Pathology. 2015 Jan;47(1):27-33
pubmed: 25474510

Auteurs

Banri Tsuda (B)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. banri@is.icc.u-tokai.ac.jp.

Nobue Kumaki (N)

Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan.

Rie Ishida (R)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Mari Mizuno (M)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Kozue Yokoyama (K)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Risa Oshitanai (R)

Department of Breast and Endocrine Surgery, Tokai University Hachioji Hospital, Hachioji, Japan.

Mayako Terao (M)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Toru Morioka (T)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Takuho Okamura (T)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Yuki Saito (Y)

Department of Breast and Endocrine Surgery, Tokai University Hachioji Hospital, Hachioji, Japan.

Yasuhiro Suzuki (Y)

Department of Breast and Endocrine Surgery, Tokai University Hachioji Hospital, Hachioji, Japan.

Naoki Niikura (N)

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

Classifications MeSH